A new staff analysis from the Senate Finance Committee says the Inflation Reduction Act’s price gouging penalty for drug makers that raise the price of Medicare Part D drugs faster than the rate of inflation has saved $3 billion for seniors and taxpayers since January 2023 and has generally slowed the rate at which companies are seeking to hike drug prices. The report highlights that 98 Part B drugs that experienced price gouging by their manufacturer have been penalized under...